BioArctic AB (publ)
BRCTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $17,881,816 | $24,013,666 | $26,555,522 | $22,225,637 |
| - Cash | $512,927 | $611,567 | $805,386 | $848,405 |
| + Debt | $54,228 | $4,979 | $10,039 | $15,877 |
| Enterprise Value | $17,423,117 | $23,407,078 | $25,760,175 | $21,393,109 |
| Revenue | $257,352 | $615,995 | $228,291 | $23,146 |
| % Growth | -58.2% | 169.8% | 886.3% | – |
| Gross Profit | $230,368 | $526,368 | $153,965 | -$31,921 |
| % Margin | 89.5% | 85.5% | 67.4% | -137.9% |
| EBITDA | -$211,190 | $295,241 | $4,025 | -$126,566 |
| % Margin | -82.1% | 47.9% | 1.8% | -546.8% |
| Net Income | -$177,079 | $229,249 | -$11,179 | -$119,789 |
| % Margin | -68.8% | 37.2% | -4.9% | -517.5% |
| EPS Diluted | -2 | 2.59 | -0.13 | -1.36 |
| % Growth | -177.2% | 2,092.3% | 90.4% | – |
| Operating Cash Flow | -$316,332 | $309,694 | -$31,638 | -$140,457 |
| Capital Expenditures | -$26,635 | -$7,443 | -$12,746 | -$4,386 |
| Free Cash Flow | -$342,967 | $302,251 | -$44,384 | -$144,843 |